Quarterly report pursuant to Section 13 or 15(d)

Revision to Prior Period Financial Statements (Tables)

v3.21.1
Revision to Prior Period Financial Statements (Tables)
3 Months Ended
Mar. 31, 2021
Revision to Prior Period Financial Statements  
Summarize the effect of the revision to the Post-IPO Balance Sheet

    

As of February 2, 2021

As Previously

Revised

  

    

Reported

    

Adjustment

    

As Revised

Balance Sheet

 

  

 

  

 

  

Total assets

$

289,785,365

$

$

289,785,365

Liabilities, redeemable non-controlling interest and shareholders’ equity

 

  

 

  

 

  

Total current liabilities

$

642,351

$

$

642,351

Deferred underwriting commissions

 

10,062,500

 

 

10,062,500

Derivative warrant liabilities

 

 

10,638,000

 

10,638,000

Total liabilities

 

10,704,851

 

10,638,000

 

21,342,851

Class A ordinary shares, $0.0001 par value; shares subject to possible redemption

 

274,080,510

 

(10,638,000)

 

263,442,510

Shareholders’ equity

 

  

 

  

 

  

Preference shares - $0.0001 par value

 

 

 

Class A ordinary shares - $0.0001 par value

 

214

 

107

 

321

Class B ordinary shares - $0.0001 par value

 

719

 

 

719

Additional paid-in-capital

 

5,030,402

 

590,767

 

5,621,169

Accumulated deficit

 

(31,331)

 

(590,874)

 

(622,205)

Total shareholders’ equity

 

5,000,004

 

 

5,000,004

Total liabilities and shareholders’ equity

$

289,785,365

$

$

289,785,365